Study of ARO-CFB in Adult Healthy Volunteers

Clinical trial NCT06209177 · COMPLETED

Trial details

NCT number: NCT06209177
Sponsor: Arrowhead Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2024-04-05
Primary completion: 2025-03-31
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.